Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021)
Powered by 
Analysis
Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 7.56% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -284.33% |
| Mar 31, 2021 | 1,348.63% |
| Dec 31, 2020 | -28.04% |
| Sep 30, 2020 | 75.00% |
| Jun 30, 2020 | 1,122.30% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 219.10% |
| Sep 30, 2019 | -92.18% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 596.46% |
| Sep 30, 2018 | 2,461.22% |
| Dec 31, 2017 | -111.35% |
| Sep 30, 2017 | 111.35% |
| Dec 31, 2016 | 95.43% |
| Sep 30, 2016 | -188.83% |
| Jun 30, 2016 | 359.42% |
| Dec 31, 2015 | -77.07% |
| Sep 30, 2015 | 24.18% |
| Jun 30, 2015 | 42.38% |